Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The present study was designed to evaluate the oral efficacy and bioavailability of ketamine. Antinociceptive efficacy was determined with the rat formalin test and oral bioavailability by the measurement of plasma and brain concentrations of ketamine and its major metabolite, norketamine. Oral ketamine in a dose range from 30 to 180 mg/kg or saline was given prior to intraplantar formalin and the flinching behavior was measured. Oral ketamine dose-dependently reduced the flinching during phase 2, while flinching during phase 1 was reduced only with the highest dose given. Following oral ketamine at 100 mg/kg, blood and brain samples were obtained and plasma and brain ketamine and norketamine levels were measured using high-performance liquid chromatography (HPLC). The average concentration ratio of norketamine/ketamine, as expressed by the area under the curve (AUC) value, was 6.4 for plasma and 2.9 for brain. These results demonstrate that a significant amount of norketamine is formed by first pass biotransformation of ketamine and is distributed to the brain. Competition binding assays for the [3H]MK-801-labeled non-competitive site of the N-methyl-D-aspartate receptor (NMDA) receptor revealed that both norketamine and ketamine displaced [3H]MK-801 at low micromolar concentrations with Ki values of 2.5 and 0.3 mM in the forebrain, and 4.2 and 1.0 mM in the spinal cord, respectively. Spinal norketamine was approximately equipotent to ketamine in producing antinociceptive effects during phase 2 of the formalin test. Thus, norketamine appears to contribute to the antinociceptive effects of oral ketamine through its NMDA receptor antagonist activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Coderre, T. J., Katz, J., Vaccarino, A. L., & Melzack, R. (1993) · Pain · doi:10.1016/0304-3959(93)90161-h · Cited by 1,966
Anis, N. A., Berry, S. C., Burton, N. R., & Lodge, D. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb11031.x · Cited by 1,399 · cited 1×
“Ketamine is a clinically available anesthetic with noncompetitive NMDA receptor antagonist activity (Anis et al., 1983; Martin and Lodge, 1985; MacDonald et al., 1987).”
BackgroundBioavailability, pharmacokinetics, and analgesic activity of ketamine in humans
Clements, J. A., Nimmo, W. S., & Grant, I. S. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600710516 · Cited by 420
Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine
MacDonald, J. F., Miljkovic, Z., & Pennefather, P. (1987) · Journal of Neurophysiology · doi:10.1152/jn.1987.58.2.251 · Cited by 387
Cited by
Kapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459
“31 Further, brain concentrations are known to be several fold higher than plasma concentrations”
BackgroundHijazi, Y., & Boulieu, R. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.7.853 · Cited by 287
Targeting the N-Methyl-d-Aspartate Receptor for Chronic Pain Management
Fisher, K., Coderre, T. J., & Hagen, N. A. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00213-x · Cited by 266
Glutamate Receptors and Nociception: Implications for the Drug Treatment of Pain
Fundytus, M. E. (2001) · CNS Drugs · doi:10.2165/00023210-200115010-00004 · Cited by 250
A REVIEW OF KETAMINE ABUSE AND DIVERSION: Review: Ketamine
Sassano-Higgins, S., Baron, D., Juarez, G., Esmaili, N., & Gold, M. (2016) · Depression and Anxiety · doi:10.1002/da.22536 · Cited by 204
Metadata
- Authors
- Shimoyama, M., Shimoyama, N., Gorman, L. A., Elliott, K. J., & Inturrisi, C. E.
- Venue
- Pain
- Published
- 1999-05-01
- Volume
- 81
- Issue
- 1
- Pages
- 85-93
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2011239975
- Cited by
- 95
- References
- 5
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine. https://app.cochat.ai/papers/10.1016/s0304-3959(98)00269-3
- The paper
- Shimoyama, M., Shimoyama, N., Gorman, L. A., Elliott, K. J., & Inturrisi, C. E. (1999). Oral ketamine is antinociceptive in the rat formalin test: role of the metabolite, norketamine. Pain. https://doi.org/10.1016/s0304-3959(98)00269-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.